Healthcare -
Biotechnology - NASDAQ - US
$ 10.58
0.666 %
$ 1.08 B
Market Cap
-1.94
P/E
NTLA - CAPITAL EXPENDITURES
Capital Expenditures NTLA - Intellia Therapeutics, Inc.
-14 M
LAST VALUE
-4.71%
2 YEAR CAGR
-17.08%
5 YEAR CAGR
0.00%
10 YEAR CAGR